CN Stock MarketDetailed Quotes

Tianjin Chase Sun Pharmaceutical (300026)

Watchlist
  • 3.42
  • -0.01-0.29%
Market Closed Apr 30 15:00 CST
10.27BMarket Cap427.50P/E (TTM)

Tianjin Chase Sun Pharmaceutical (300026) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Prescription granules and tablets of traditional Chinese Medicine2.46B49.81%
Xuebijing injection938.97M19.00%
Medical device products331.37M6.71%
药械智慧供应链256.56M5.19%
Excipient medicine217.08M4.39%
Other products180.85M3.66%
Low molecular weight heparin calcium injection171.33M3.47%
Raw material medicine158.45M3.21%
依诺肝素钠注射液154.65M3.13%
Other70.93M1.44%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Prescription granules and tablets of traditional Chinese Medicine2.46B49.81%
Finished product medicine1.38B27.86%
medical apparatus587.93M11.90%
Excipients and APIs428.24M8.67%
Other87.2M1.76%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
North China1.28B25.92%
East China region1.22B24.77%
Central China830.77M16.81%
overseas market392.87M7.95%
Southwest area384.36M7.78%
South China315.91M6.39%
Northeast area259.54M5.25%
Northwest region252.8M5.12%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More